|

Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist

RECRUITINGN/ASponsored by Next Biomedical Co., Ltd.
Actively Recruiting
PhaseN/A
SponsorNext Biomedical Co., Ltd.
Started2023-07-13
Est. completion2026-07-13
Eligibility
Age19 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06207851

Summary

In patients with chronic elbow or wrist pain, the pain is controlled by conventional conservative therapy The pain reduction effect of Nexsphere-F embolization in patients who need additional treatment It is intended to demonstrate safety.

Eligibility

Age: 19 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Those aged 19 to 80
2. Anyone who can provide a consent form
3. A person with a life expectancy of at least 12 months
4. Those who have not responded or failed in preservation treatment for at least three months(e.g. NSAIDS/physical therapy/steroidal joint injections, etc.)
5. VAS score of 4 or higher and moderate-severe elbow or wrist pain

Exclusion Criteria:

1. Those with a VAS Score of less than 4 and Mild Elbow or Wrist Pain
2. Chronic Renal Insufficiency(Serum creatinine \> 2mg/dL)
3. allergy to iodide contrast agents that do not respond to steroids
4. Those with acute infection or malignancy
5. Those who have previously had elbow or wrist surgery
6. Those with Bleeding Diabetes that cannot be calibrated

Conditions2

ArthritisOsteoarthritis

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.